Your browser doesn't support javascript.
loading
BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.
Ljung, R; Kenet, G; Mancuso, M E; Kaleva, V; Rusen, L; Tseneklidou-Stoeter, D; Michaels, L A; Shah, A; Hong, W; Maas Enriquez, M.
Affiliation
  • Ljung R; Department of Clinical Sciences Lund-Pediatrics, Malmö Centre for Thrombosis and Haemostasis, Skåne University Hospital, Lund University, Malmö, Sweden.
  • Kenet G; Chaim Sheba Medical Center, The Israeli National Hemophilia Center, The Sackler Medical School, Tel Aviv University, Tel-Hashomer, Israel.
  • Mancuso ME; Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  • Kaleva V; MHAT Sveta Marina, Clinic of Pediatric Hematology and Oncology, Varna, Bulgaria.
  • Rusen L; SC Sanador SRL, Bucharest, Romania.
  • Tseneklidou-Stoeter D; Bayer Pharma AG, Berlin, Germany.
  • Michaels LA; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA.
  • Shah A; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA.
  • Hong W; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA.
  • Maas Enriquez M; Bayer Pharma AG, Wuppertal, Germany.
Haemophilia ; 22(3): 354-60, 2016 May.
Article in En | MEDLINE | ID: mdl-26663410

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor VIII / Coagulants / Hemophilia A Type of study: Clinical_trials / Prognostic_studies Limits: Child / Child, preschool / Humans / Infant / Male Language: En Journal: Haemophilia Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor VIII / Coagulants / Hemophilia A Type of study: Clinical_trials / Prognostic_studies Limits: Child / Child, preschool / Humans / Infant / Male Language: En Journal: Haemophilia Year: 2016 Document type: Article